Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
Ticker SymbolPLRZ
Company namePolyrizon Ltd
IPO dateOct 29, 2024
CEOMr. Tomer Izraeli
Number of employees1
Security typeOrdinary Share
Fiscal year-endOct 29
AddressHaTidhar St. 5
CityRA'ANANA
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code- -
Phone97293740120
Websitehttps://polyrizon-biotech.com/
Ticker SymbolPLRZ
IPO dateOct 29, 2024
CEOMr. Tomer Izraeli
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data